HomeCompareNUZE vs JNJ

NUZE vs JNJ: Dividend Comparison 2026

NUZE yields 267.31% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NUZE wins by $707.06M in total portfolio value
10 years
NUZE
NUZE
● Live price
267.31%
Share price
$0.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$707.08M
Annual income
$407,322,832.45
Full NUZE calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NUZE vs JNJ

📍 NUZE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNUZEJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NUZE + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NUZE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NUZE
Annual income on $10K today (after 15% tax)
$22,721.20/yr
After 10yr DRIP, annual income (after tax)
$346,224,407.58/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, NUZE beats the other by $346,223,703.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NUZE + JNJ for your $10,000?

NUZE: 50%JNJ: 50%
100% JNJ50/50100% NUZE
Portfolio after 10yr
$353.55M
Annual income
$203,661,830.12/yr
Blended yield
57.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NUZE
No analyst data
Altman Z
-1.9
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NUZE buys
0
JNJ buys
0
No recent congressional trades found for NUZE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNUZEJNJ
Forward yield267.31%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$707.08M$20.0K
Annual income after 10y$407,322,832.45$827.78
Total dividends collected$675.83M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NUZE vs JNJ ($10,000, DRIP)

YearNUZE PortfolioNUZE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$37,431$26,730.82$10,676$355.77+$26.8KNUZE
2$133,561$93,509.96$11,407$389.39+$122.2KNUZE
3$454,745$311,834.52$12,198$426.53+$442.5KNUZE
4$1,478,844$992,267.18$13,056$467.62+$1.47MNUZE
5$4,598,142$3,015,779.29$13,987$513.12+$4.58MNUZE
6$13,683,477$8,763,464.28$14,998$563.56+$13.67MNUZE
7$39,014,157$24,372,836.83$16,098$619.52+$39.00MNUZE
8$106,690,500$64,945,351.79$17,295$681.69+$106.67MNUZE
9$280,143,443$165,984,608.79$18,599$750.82+$280.12MNUZE
10$707,076,317$407,322,832.45$20,022$827.78+$707.06MNUZE

NUZE vs JNJ: Complete Analysis 2026

NUZEStock

NuZee, Inc., a specialty coffee company, engages in the manufacture, packing, and sale of single serve coffee and tea bag-style coffee for coffee roasters and suppliers in North America and South Korea. The company provides its products under Coffee Blenders, Twin Peaks, and Pine Ranch brands. It serves retail and grocery customers, office, and hospitality sectors. NuZee, Inc. was incorporated in 2011 and is headquartered in Plano, Texas.

Full NUZE Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NUZE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NUZE vs SCHDNUZE vs JEPINUZE vs ONUZE vs KONUZE vs MAINNUZE vs ABBVNUZE vs MRKNUZE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.